Environmental, Social And Governance Report

Overview

The report describes Luye Pharma's 2023 ESG governance, materiality process and oversight by the Board and ESG Committee. It reports 5,270 employees, with 2,798 female and 2,472 male staff, and no employee or contractor fatalities. Environmental disclosures include 76,201.35 Tons of total greenhouse gas emissions, 1,210,415.00 Cubic meters of water consumption and 1,971.00 Tons of waste generated, calculated from the reported hazardous and non-hazardous waste totals. The report also highlights pharmaceutical innovation, ISO-certified management systems, sustainable supplier practices and patient-access initiatives.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services